These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 65851)

  • 1. [CEA-course determinations in the serum of patients with ulcerative colitis].
    Lamerz R; Rindfleisch GE; Ruider H; Koczorek KR
    Z Gastroenterol Verh; 1976; (11):105-8. PubMed ID: 65851
    [No Abstract]   [Full Text] [Related]  

  • 2. [CEA-determinations in the serum of patients with carcinoma of the large intestine].
    Lamerz R; Ruider H
    Z Gastroenterol Verh; 1976; (11):79-84. PubMed ID: 65869
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical value of the plasma-CEA-concentrations for the activity control of chronic inflammatory intestinal diseases].
    Auer IO; Schmid L; Ziemer E; Sommer H; Epping J
    Z Gastroenterol Verh; 1976; (11):109-12. PubMed ID: 65852
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the evaluation of the tissue proliferation specific marker (TPS) and the carcinoembryonal antigen (CEA) in patients with ulcerative colitis and adenocarcinoma.
    Krauss H; Ignyś I; Kopczyński Z; Piatek J
    Med Sci Monit; 2002 Jan; 8(1):CR48-51. PubMed ID: 11791131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Computer-supported postoperative CEA-course controls : correlation with the prognosis of recurrence and findings of second-look operations].
    Staab HJ; Anderer FA; Stumpf E; Fischer R
    Z Gastroenterol Verh; 1976; (11):85-9. PubMed ID: 65870
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma.
    Mach JP; Pusztaszeri G; MacDonald D; Bertholet MM
    Johns Hopkins Med J Suppl; 1974; 3():369-79. PubMed ID: 4421371
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis.
    Smithson JE; Warren BF; Young S; Pigott R; Jewell DP
    J Pathol; 1996 Oct; 180(2):146-51. PubMed ID: 8976872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: CEA estimation in ulcerative colitis with and without malignant change.
    Dilawari JB; Lennard-Jones JE
    Gut; 1974 Oct; 15(10):828. PubMed ID: 4434941
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimation of carcinoembryonic antigen in ulcerative colitis with special reference to malignant change.
    Dilawari JB; Lennard-Jones JE; Mackay AM; Ritchie JK; Sturzaker HG
    Gut; 1975 Apr; 16(4):255-60. PubMed ID: 1132800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in carcinoembryonic antigen in patients with breast cancer].
    Papaleo G; Zito GA; Gambardella A; Colella C
    Boll Soc Ital Biol Sper; 1982 Dec; 58(23):1577-81. PubMed ID: 7165764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical value of the plasma-CEA-concentrations in the primary diagnosis of malignoma of the digestive tract].
    Aver IO; Münch L; Epping J; Schmid L
    Z Gastroenterol Verh; 1976; (11):73-7. PubMed ID: 65868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concentration of selenium in serum of patients with ulcerative colitis].
    Jendryczko A; Drózdz M; Kozłowski A; Pardela M
    Przegl Lek; 1992; 49(9):292-3. PubMed ID: 1302352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
    Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
    Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methodical accomplishment and results of quality control attempts in the CEA determination using a commercial radioimmunoassay kit].
    Neumeier D; Glück B; Fateh-Moghadam A; Knedel M
    Z Gastroenterol Verh; 1976; (11):71-2. PubMed ID: 65867
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum lysozyme in inflammatory bowel disease.
    Nugent FW; Mallari R; George H; Ridley N
    Gastroenterology; 1976 Jun; 70(6):1014-6. PubMed ID: 1269861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
    Rosman-Urbach M; Niv Y; Birk Y; Smirnoff P; Zusman I; Morgenstern S; Schwartz B
    Dis Colon Rectum; 2004 Mar; 47(3):304-13. PubMed ID: 14991492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum carcinoembryonic antigen (CEA) in patients with chronic inflammatory bowel disease.
    Turner MD; Kleinman MS; Thayer W
    Digestion; 1973; 9(2):116-23. PubMed ID: 4772021
    [No Abstract]   [Full Text] [Related]  

  • 20. The carcinoembryonic antigen (CEA) radioimmunoassay.
    Thomson D
    Proc R Soc Med; 1972 Jul; 65(7):635-6. PubMed ID: 5085944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.